These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4027506)

  • 1. Immunohistological detection of T antigen and ABH blood group antigens in upper urinary tract tumours.
    Kagawa S; Takigawa H; Ghazizadeh M; Kurokawa K
    Br J Urol; 1985 Aug; 57(4):386-9. PubMed ID: 4027506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y; Satoh T
    Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic validity of the specific red cell adherence test in upper urothelial tumours.
    Ghazizadeh M; Numata A; Kagawa S; Fujimura N; Kurokawa K
    Br J Urol; 1983 Oct; 55(5):473-6. PubMed ID: 6626891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cell surface antigen in cancer of renal pelvis and ureter.
    Lippert M; Bergman S; Walker P; Berger C; Javadpour N
    Urology; 1983 Oct; 22(4):366-8. PubMed ID: 6636390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
    Yamada T; Fukui I; Yokogawa M; Oshima H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
    [No Abstract]   [Full Text] [Related]  

  • 9. [CEA and ABO antigens as early signs of malignancy in urotheliomas of the upper urinary tract].
    Cisternino A; Argona F; Garbeglio A; Ranieri A; Bassi P; Pergoraro V
    Arch Esp Urol; 1986 Oct; 39(8):529-33. PubMed ID: 3827317
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic factors for progression of superficial bladder cancer].
    Sato N; Sumiya H; Isaka S; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder.
    Malmström PU; Norlén BJ; Andersson B; Busch C
    Br J Urol; 1989 Jul; 64(1):49-55. PubMed ID: 2765768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitional cell carcinoma of upper urinary tract: some prognostic indicators.
    Gawley WF; Harney J; Glacken P; Hehir M; Rogers A; McKelvie G
    Urology; 1989 Jun; 33(6):459-61. PubMed ID: 2728147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of blood group antigens in urinary tract tumours: prospective fluorescence study using cryostat sections of fresh frozen tissues.
    Thorpe SJ; Abel P; Henderson D; Jones N; Feizi T
    J Clin Pathol; 1986 Nov; 39(11):1165-76. PubMed ID: 3540013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-antigen in normal and neoplastic urothelium.
    Limas C; Lange P
    Cancer; 1986 Sep; 58(6):1236-45. PubMed ID: 3742450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood group precursor T-antigen expression in human urinary bladder carcinoma.
    Coon JS; Weinstein RS; Summers JL
    Am J Clin Pathol; 1982 Jun; 77(6):692-9. PubMed ID: 7091049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    van Oers JM; Zwarthoff EC; Rehman I; Azzouzi AR; Cussenot O; Meuth M; Hamdy FC; Catto JW
    Eur Urol; 2009 Mar; 55(3):650-7. PubMed ID: 18584939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.